Fedora Pharmaceuticals Highlights Efficacy of Novel Antibiotic, FPI-2119, against Antimicrobial-resistant Gram-negative Bacteria at the 2026 IMARI Conference

FPI-2119 offers potential solution to multi-drug-resistant Gram-negative infectionsEDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of ...
BioTechniques

Protein in an envelope: spilling a Gram-negative bacterium’s secrets

Researchers have determined a protein’s essential role in bacterial envelope structure and function, which could inspire a search for better antibiotics. Researchers at Johns Hopkins University (MD, ...
Santé log

smartbax in-licenses lead antibacterial compound targeting Gram-negative infections from Aicuris

The licensing agreement significantly broadens smartbax’s pipeline of antibacterial compounds with novel mechanisms. The new program addresses the urgent unmet medical need for effective therapies ...